Home NDC 42937-702 Phenazopyridine Hydrochloride
Product NDC 42937-702
11-digit product format 429370702
Labeler code 42937
Product ID 42937-702_edc15341-9bca-4088-8e91-668e7c66ae25
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Phenazopyridine Hydrochloride
Dosage form TABLET, COATED
Route ORAL
Labeler Nationwide Laboratories, LLC
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2011-08-02
Marketing end 0000-00-00
Substance PHENAZOPYRIDINE HYDROCHLORIDE
Active strength 200 mg/1
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 39 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 42937-702-16 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 42937-702-10 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 42937-702-16 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 42937-702-10 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 42937-702-16 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 42937-702-10 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 42937-702-16 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 42937-702-10 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 42937-702-16 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 42937-702-10 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 42937-702-16 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 42937-702-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 42937-702-16 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 42937-702-10 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 42937-702-16 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 42937-702-10 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 42937-702-16 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 42937-702-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 42937-702-16 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 42937-702-10 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 42937-702-16 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 42937-702-10 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 42937-702-16 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 42937-702-10 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 42937-702-16 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 42937-702-10 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Phenazopyridine Hydrochloride ACTIVE INGREDIENT 0EWG668W17 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Phenazopyridine ACTIVE MOIETY K2J09EMJ52 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Cellulose, Microcrystalline INACTIVE INGREDIENT OP1R32D61U PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Croscarmellose Sodium INACTIVE INGREDIENT M28OL1HH48 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Hypromelloses INACTIVE INGREDIENT 3NXW29V3WO PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Magnesium Stearate INACTIVE INGREDIENT 70097M6I30 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Mineral Oil INACTIVE INGREDIENT T5L8T28FGP PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Povidones INACTIVE INGREDIENT FZ989GH94E PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Propylene Glycol INACTIVE INGREDIENT 6DC9Q167V3 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Silicon Dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1 Starch, Corn INACTIVE INGREDIENT O8232NY3SJ PHENAZOPYRIDINE HYDROCHLORIDE TABLET, COATED [NATIONWIDE LABORATORIES, LLC] 1
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 42937-702-10 42937070210 100 TABLET, COATED in 1 BOTTLE (42937-702-10) 2011-08-02 0000-00-00 No No Current 42937-702-16 42937070216 250 TABLET, COATED in 1 BOTTLE (42937-702-16) 2011-08-02 0000-00-00 No No Current